Abrocitinib Expanded Access Protocol in Adolescents and Adults With Moderate to Severe Atopic Dermatitis
Public ClinicalTrials.gov record NCT04564755. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
ABROCITINIB EXPANDED ACCESS PROTOCOL FOR THE TREATMENT OF ADOLESCENTS AND ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multi-center, expanded access protocol to provide access to the investigational product, abrocitinib, to adolescent and adult patients with moderate to severe atopic dermatitis who have inadequate treatment options with available and approved medicated topical and systemic therapies and who are otherwise ineligible for participation in clinical studies with abrocitinib.
Study identification
- NCT ID
- NCT04564755
- Recruitment status
- No Longer Available
- Study type
- Expanded access
- Phase
- Not listed
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Oct 28, 2024
United States locations
- U.S. sites
- 21
- U.S. states
- 13
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cahaba Dermatology and Skin Health Center | Birmingham | Alabama | 35244 | — |
| Antelope Valley Clinical Trials | Lancaster | California | 93534 | — |
| Allergy & Asthma Care Center | Long Beach | California | 90808 | — |
| Beach Allergy and Asthma Specialty Group, A Medical Corporation | Long Beach | California | 90808 | — |
| ACRC Studies | San Diego | California | 92119 | — |
| Palm Beach Dermatology | Delray Beach | Florida | 33484 | — |
| Skin Care Research | Hollywood | Florida | 33021 | — |
| L&C Professional Medical Research Institute | Miami | Florida | 33144 | — |
| Sarasota Clinical Research | Sarasota | Florida | 34239 | — |
| Precision Clinical Research | Sunrise | Florida | 33351 | — |
| Dundee Dermatology | West Dundee | Illinois | 60118 | — |
| Qualmedica Research, LLC | Evansville | Indiana | 47715 | — |
| Bluegrass Allergy Research | Lexington | Kentucky | 40509 | — |
| Respiratory Medicine Research Institute of Michigan, PLC | Ypsilanti | Michigan | 48197 | — |
| Bexley Dermatology Research | Bexley | Ohio | 43209 | — |
| Hightower Clinical Trial Services - Lam Dermatology | Norman | Oklahoma | 73072 | — |
| Health Concepts | Rapid City | South Dakota | 57702 | — |
| Clinical Neuroscience Solutions, Inc. dba CNS Healthcare | Memphis | Tennessee | 38119 | — |
| Center for Clinical Studies, LTD. LLP | Houston | Texas | 77004 | — |
| Houston Medical Imaging | Houston | Texas | 77072 | — |
| West Virginia Research Institute | Morgantown | West Virginia | 26505 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 36 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04564755, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 28, 2024 · Synced Sep 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04564755 live on ClinicalTrials.gov.